课题基金 / 基金详情

Drug Resistance, Antigenic Variation And Disease Severit

Drug Resistance, Antigenic Variation And Disease Severit
耐药性、抗原变异和疾病严重程度
批准号:
7299938
负责人:
Thomas E Wellems
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Thomas E Wellems的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Our research program focuses on four subject areas: [1] drug resistance of malaria parasites and the factors that affect clinical outcomes after antimalarial treatment; [2] the means by which malaria parasites avoid human immune defenses; [3] why strains of the most deadly malaria parasite (Plasmodium falciparum) show different infectivities to the cells of humans and other primates; and [4] the nature of protection against malaria that is conferred to children by such hemoglobin mutations and red blood cell polymorphisms as hemoglobin C, hemoglobin S, and G6PD deficiency. In each of these areas we seek research advances that can improve the knowledge of disease processes in malaria and thereby support the development of new antimalarial chemotherapies, diagnostic tools, and vaccines. The research activities in our program are multidisciplinary and include field studies in malarious regions as well as programs of basic laboratory investigation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Malaria Pathogenesis and Clinical Immunity
Malaria Drug Resistance and Disease Virulence
Biochemical And Biophysical Parasitology
Dry Season Ecology of Malaria Vectors
国内基金
海外基金
Naringin通过改善Leptin Resistance调节肠上皮AQP3重建糖脂代谢平衡的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    周烨
  • 依托单位:
E-cadherin调控卵巢癌细胞anoikis-resistance的分子机制及干预
  • 批准号:
    81172487
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2011
  • 负责人:
    刘联
  • 依托单位: